OM1, Inc.

Behind the Insights

Technology EN ↓ 6 episodes

Welcome to Behind the Insights! A series where the industry’s top thought leaders share real-world data (RWD), artificial intelligence (AI), and evidence generation insights.

Author

OM1, Inc.

Episodes

Behind the Insights: Ep 06 FDA Draft Guidance on Post-Approval Data for Cell & Gene Therapies 04.11.2025 10:24

In this episode of Behind the Insights, Rich Gliklich, MD, Founder and CEO and Michelle Leavy, MPH, Senior Director, Registries at OM1 unpack the FDA's new draft guidance on Postapproval Methods to Capture Safety and Efficacy Data for Cell and Gene Therapy Products. They'll discuss practical considerations sponsors need to know and provide expert insights on compliant, cost-effective postapproval...

Behind the Insights: Ep 05 Rheumatoid Arthritis Remission with Chandra Gopalakrishnan, MD, MPH 04.11.2025 5:25

In this episode of Behind the Insights, Chandra Gopalakrishnan, MD, MPH, Principal Epidemiologist at OM1, discusses an award winning ISPOR poster that investigates predictors of low disease activity or remission in rheumatoid arthritis (RA). Despite the vast availability of therapies, many rheumatoid arthritis patients still fail to achieve remission, highlighting the need for more effective treat...

Behind the Insights: Ep 04 GLP-1s & Suicidal Ideation, Jessica Probst, MPH & Carl Marci, MD 04.11.2025 4:06

In this episode of Behind the Insights, Jessica Probst, MPH, Principal, Real-World Evidence at OM1 and Dr. Carl Marci, Chief Clinical Officer and Managing Director of Mental Health and Neuroscience at OM1, unpack a topic that’s made recent headlines and raised important questions for both clinicians and patients, suicidal ideation (SI) warnings on GLP-1 medications. While these labels have sparked...

Behind the Insights: Ep 03 Decoding Treatment-Resistant Depression with Carl Marci, MD 04.11.2025 5:32

In this episode of Behind the Insights, Carl D. Marci, MD, Chief Clinical Officer and Managing Director of Mental Health and Neuroscience at OM1, explores the complexities of Treatment-Resistant Depression (TRD) and how OM1’s AI-driven models are reshaping the way we identify and treat patients. Discover how real-world data, clinician attestation, and unstructured clinical notes are unlocking hidd...

Behind the Insights: Ep 02 The Next Era of Evidence Generation with Rich Gliklich, MD 04.11.2025 12:32

In this episode of Behind the Insights, OM1 CEO, Rich Gliklich, MD explores the groundbreaking advancements reshaping evidence generation in clinical research. From AI-driven automation in clinical trials to the power of passive data collection, discover how these innovations are reducing costs, accelerating research, and paving the way for personalized medicine. 0:00 Intro 0:46 Real-world data is...

Behind the Insights: Ep 01 AI in Dermatology Real-World Data with Joseph Zabinski, PhD, MEM 04.11.2025 19:18

Welcome to the first episode of Behind the Insights! A series where we share real-world data (RWD), artificial intelligence (AI), and evidence generation insights from the industry’s top thought leaders. Many are familiar with the promise of AI through applications such as Chat GPT and virtual assistants like Google Gemini, but this episode focuses on how AI can enhance RWD in dermatology data. 0:...